HNPCC
8
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Pancreatic Cancer Early Detection Program
Molecular Screening for Lynch Syndrome in Denmark
Uncertain Genetic Test Results for Lynch Syndrome
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
I-Scan For Colon Polyp Detection In HNPCC
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Molecular Screening for Lynch Syndrome in Southern Denmark